Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC): A Phase II Clinical Study

NCT01984892 is registered in ClinicalTrials.gov with Nina Bhardwaj as lead sponsor.

NCT NCT01984892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01984892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC): A Phase II Clinical Study
Lead sponsor
Nina Bhardwaj
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2013
Completion date
August 31, 2014
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell cancer of the skin, breast cancer, melanoma, sarcoma of the skin, squamous cell carcinoma of the head and neck, squamous cell carcinoma of the skin